INFU Company Profile and Key Details

Q: Who are the executives of INFU?

Mr. Barry G. SteeleExecutive Vice President & Chief Financial OfficerMr. Thomas Mark RuizExecutive Vice President & Chief Commercial OfficerJeanie LatzCorporation Sec.Ms. Jeannine Lombardi SheehanExecutive Vice President & Chief Admin. OfficerMr. Richard A. DiIorioChief Executive Officer & DirectorMs. Carrie Lachance B.S.N., M.B.A., R.N.Pres, Chief Operating Officer & DirectorMr. Addam ChupaExecutive Vice President & Chief Information OfficerMs. Carrie A. Lachance B.S.N., M.B.A., R.N.Pres, Chief Operating Officer & Director

AMEX : INFU

InfuSystem

$9.29

-0.00999958-0.11%

At Close 4:00 PM

77.57

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

InfuSystem Holdings, Inc. (INFU) stock declined over -0.11%, trading at $9.29 on AMEX, down from the previous close of $9.30. The stock opened at $9.11, fluctuating between $8.93 and $9.40 in the recent session.

Stock Snapshot

9.3

Prev. Close

188.92M

Market Cap

8.93

Day Low

29.97

P/E Ratio

0.31

EPS (TTM)

0.07

Cash Flow per Share

9.11

Open

20.34M

Number of Shares

9.395

Day High

88.52%

Free Float in %

2.47

Book Value

55.97K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2026	9.11	9.40	8.93	9.29	59.03K
Apr 01, 2026	9.26	9.43	9.06	9.30	66.51K
Mar 31, 2026	9.50	9.50	9.12	9.23	87.94K
Mar 30, 2026	9.60	9.63	9.15	9.35	166.55K
Mar 27, 2026	9.71	9.71	9.41	9.54	72.73K
Mar 25, 2026	9.76	9.85	9.60	9.79	61.68K
Mar 24, 2026	9.42	9.74	9.40	9.69	106.79K
Mar 23, 2026	9.23	9.67	9.11	9.60	109.92K
Mar 20, 2026	9.44	9.45	8.72	9.09	191.86K
Mar 19, 2026	9.53	9.64	9.30	9.55	98.44K
Mar 18, 2026	9.77	9.79	9.57	9.62	100.24K
Mar 17, 2026	9.60	9.83	9.60	9.83	135.18K
Mar 16, 2026	9.40	9.76	9.32	9.57	110.7K
Mar 13, 2026	9.39	9.43	9.23	9.31	82.34K
Mar 12, 2026	9.47	9.62	9.32	9.39	100.54K
Mar 11, 2026	9.70	9.82	9.46	9.61	75.85K
Mar 10, 2026	9.69	9.91	9.62	9.68	92.34K
Mar 09, 2026	9.37	9.84	9.37	9.83	144.32K
Mar 06, 2026	9.57	9.58	9.23	9.48	96.06K
Mar 03, 2026	9.19	9.41	8.92	9.18	177.78K

Contact Details

Rochester Hills, MI 48309

United States

https://www.infusystem.com 248 291 1210

About Company

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Stock Peers

RGNT

0.11+3.67%

Regentis Biomaterials Ltd.$3.11 STXS

0.02+1.08%

Stereotaxis, Inc.$1.87 RVP

0.0219+3.29%

Retractable Technologies, Inc.$0.69 MLSS

-0.0145-4.86%

Milestone Scientific Inc.$0.28

Company Overview

InfuSystem Holdings, Inc. (AMEX:INFU) closed at $9.29 USD, losing -$0.01 (-0.11%) from the previous close of $9.30. The stock is currently mid-range between its 52-week high and low $4.61 and $11.04. With a market capitalization of about $188.92 million, InfuSystem Holdings, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.55). Key stats such as the average daily volume over the past year has been around 129.07 thousand shares, volume is running light vs its 52-week average. Headquartered in Rochester Hills, MI, InfuSystem Holdings, Inc. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO Carrie A. Lachance, the company employs approximately 502 people and listed since December 27, 2007. InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 15.7%, SMA50 8.42%, SMA200 10.65%). The stock’s 14-day RSI is 66.29 (firm momentum), while the ATR of 0.4 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -16.76% below its high and over 99.35% above its low. Average 10-day trading volume of 90.55 thousand shares is below the 3-month average of 126.84 thousand, indicating normal recent market interest.

Valuation Metrics

InfuSystem Holdings, Inc. trades at a P/E ratio of 28.45, slightly below the S&P 500 average, with a price-to-sales ratio of 1.32 and a price-to-book ratio of 3.29 trading at moderately above to book value. The P/FCF stands at 8.28, also below market averages.

Dividend & Fair Value

InfuSystem Holdings, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $4.38. This means the shares are trading above this model’s fair value.

Earnings & Analyst Outlook

InfuSystem Holdings, Inc. generated EPS of $0.32 over the past year. Five-year average earnings growth is -17.01%. The latest quarter delivered EPS of $0.11. The next quarter is forecast at $0.03. Next year's EPS is expected at $258.33. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $15.00 to $12.00. The high target offers 61.46% upside. The low target suggests 29.17% downside. The mean target is $14.00. This offers 50.7% upside. InfuSystem Holdings, Inc. earnings surprise history is a mixed track record. The quarter that ended November 04, 2025, missed forecasts by 33.38%. The prior quarter beat by 300.0%. Over the last six quarters, Apple has recorded several small beats. These include -18.92% in August 08, 2024.

Shareholding & Insider Activity

InfuSystem Holdings, Inc. has 20.43 million shares outstanding. The public float is 18.07 million shares, elevated short interest at 0.74% of float. This equals 141.52 thousand shares. The short ratio is 1.24 days. Institutional investors hold 81.03% of the float. Insiders own 6.61%. Meridian OHC Partners, LP holds 2.74 million shares, AWM Investment Company, Inc. has 2.00 million shares and BlueLine Capital Partners II, L.P. has 493.66 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Financial & Profitability Overview

Over the trailing twelve months, InfuSystem generated $125.79M in revenue, or $5.81 per share. Gross margin was 48.51%, operating margin 3.25%, and net profit margin 0.69%. Returns are modest, with ROA at 0.79% and ROE at 1.67%.
On valuation metrics, InfuSystem trades at a P/E of 28.45, P/S of 1.32 and P/B of 3.29. The current ratio is 1.80 and quick ratio is 1.53. Operationally, the company’s inventory turnover is 11.71 and cash conversion cycle is 26.89 days. Debt-to-equity is 0.06, supported by a cash flow-to-debt ratio of 7.12.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, InfuSystem posted revenue of $125.79M, down slightly from $109.91M in the prior quarter. Gross profit was $61.02M (margin 48.51%). Operating income was $4.09M (margin 3.2%). Net income was$872.00K (EPS $0.04).
The company ended the quarter with $231.00K in cash and short-term investments, a total debt of $36.37M, and net debt of $36.14M. Total assets were $109.89M, with equity of $52.30M. Financials further reflected stability, with operating cash flow of $10.99M, free cash flow of $9.97M, and capital expenditures of - $1.02M.

Price Forecast & Outlook

Our AI price prediction model suggests that InfuSystem Holdings, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.11%, with price expected at $9.30 by April 16, 2026, within a range of $8.95 to $9.67 3-Month Outlook: Projected rise of 72.55%, reaching $16.03 by July 01, 2026, with a range of $15.68 to $16.64. 1-Year Outlook: Projected gain of 232.51%, with price at $30.89 by April 02, 2027, within a range of $33.10 to $37.87.

Key Takeaways

InfuSystem Holdings, Inc. (AMEX:INFU) shares are flat -6.35% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows InfuSystem Holdings, Inc. trading at a premium to the broader market with a P/E of 28.45. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $18.56, suggesting 99.78% upside. Our AI forecast model points to short-term strength (0.11% over two weeks), a medium-term rise (72.55% over three months), and a longer-term gain (232.51% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current InfuSystem Holdings, Inc. (INFU) stock price?

InfuSystem Holdings, Inc. (AMEX: INFU) stock price is $9.29 in the last trading session. During the trading session, INFU stock reached the peak price of $9.40 while $8.93 was the lowest point it dropped to. The percentage change in INFU stock occurred in the recent session was -0.11% while the dollar amount for the price change in INFU stock was - $0.01.

INFU's industry and sector of operation?

The AMEX listed INFU is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. InfuSystem Holdings, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of INFU?

Mr. Barry G. Steele
Executive Vice President & Chief Financial Officer
Mr. Thomas Mark Ruiz
Executive Vice President & Chief Commercial Officer
Jeanie Latz
Corporation Sec.
Ms. Jeannine Lombardi Sheehan
Executive Vice President & Chief Admin. Officer
Mr. Richard A. DiIorio
Chief Executive Officer & Director
Ms. Carrie Lachance B.S.N., M.B.A., R.N.
Pres, Chief Operating Officer & Director
Mr. Addam Chupa
Executive Vice President & Chief Information Officer
Ms. Carrie A. Lachance B.S.N., M.B.A., R.N.
Pres, Chief Operating Officer & Director

How INFU did perform over past 52-week?

INFU's closing price is 101.52% higher than its 52-week low of $4.61 where as its distance from 52-week high of $11.04 is -15.85%.

How many employees does INFU have?

Number of INFU employees currently stands at 502.

Link for INFU official website?

Official Website of INFU is: https://www.infusystem.com

How do I contact INFU?

INFU could be contacted at phone 248 291 1210 and can also be accessed through its website. INFU operates from 3851 West Hamlin Road, Rochester Hills, MI 48309, United States.

How many shares of INFU are traded daily?

INFU stock volume for the day was 55.97K shares. The average number of INFU shares traded daily for last 3 months was 129.07K.

What is the market cap of INFU currently?

The market value of INFU currently stands at $188.92M with its latest stock price at $9.29 and 20.34M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	502
Beta	1.63
Sales or Revenue	$125.79M
5Y Sales Change%	0.909%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Instruments & Supplies

INFU Company Profile and Key Details

InfuSystem

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Earnings & Analyst Outlook

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook